Pages that link to "Q34187996"
Jump to navigation
Jump to search
The following pages link to Statin-associated myopathy (Q34187996):
Displaying 50 items.
- Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians (Q21092898) (← links)
- Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo (Q21261269) (← links)
- Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspective (Q24594814) (← links)
- Association between statin-associated myopathy and skeletal muscle damage (Q24655191) (← links)
- The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity (Q24681859) (← links)
- Unmet Needs in LDL-C Lowering: When Statins Won't Do! (Q26741705) (← links)
- Benefits & risks of statin therapy for primary prevention of cardiovascular disease in Asian Indians - a population with the highest risk of premature coronary artery disease & diabetes (Q26853571) (← links)
- Niacin, an old drug with a new twist (Q27002774) (← links)
- Treatment of dyslipidemia with statins and physical exercises: recent findings of skeletal muscle responses (Q27006481) (← links)
- Muscular effects of statins in the elderly female: a review (Q27023343) (← links)
- Overcoming Challenges With Statin Therapy (Q28073319) (← links)
- Pharmacogenomics of statins: understanding susceptibility to adverse effects (Q28079822) (← links)
- Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise (Q28086884) (← links)
- Rhabdomyolysis: pathogenesis, diagnosis, and treatment (Q28087634) (← links)
- Rhabdomyolysis and renal failure associated with gemfibrozil monotherapy (Q28166923) (← links)
- Long-term statin safety and efficacy in secondary prevention: can combination therapy improve outcomes? (Q28167386) (← links)
- Rhabdomyolysis in association with simvastatin and amiodarone (Q28168134) (← links)
- Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review (Q28220294) (← links)
- Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver (Q28243492) (← links)
- Niacin extended-release/simvastatin (Q28299261) (← links)
- Rhabdomyolysis associated with the nutritional supplement Hydroxycut (Q28306610) (← links)
- Exploration of the association rules mining technique for the signal detection of adverse drug events in spontaneous reporting systems (Q28481360) (← links)
- RNA-sequencing analysis of HepG2 cells treated with atorvastatin (Q28542543) (← links)
- Hypothyroidism complicating nephropathy in a diabetes patient (Q28710219) (← links)
- Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins (Q29547856) (← links)
- Statin intolerance - a question of definition (Q30245218) (← links)
- Combination therapy of dyslipidemia in non-insulin-dependent diabetes mellitus and the metabolic syndrome. (Q30434678) (← links)
- Alterations in zebrafish development induced by simvastatin: Comprehensive morphological and physiological study, focusing on muscle. (Q30823700) (← links)
- Hypothyroidism and dyslipidemia: modern concepts and approaches (Q33207919) (← links)
- Pharmacogenomics: candidate gene identification, functional validation and mechanisms (Q33375573) (← links)
- The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies (Q33440652) (← links)
- Rhabdomyolysis in community acquired bacterial sepsis--a retrospective cohort study (Q33507272) (← links)
- Anticipating the evolution of clinical cholesterol guidelines: implications of recent statin intervention trials (Q33508676) (← links)
- Statin-induced rhabdomyolysis: a comprehensive review of case reports (Q33551640) (← links)
- Statin Induced Rhabdomyolysis with Non Oliguric Renal Failure: A Rare Presentation (Q33666411) (← links)
- Statin induced myopathy presenting as mechanical musculoskeletal pain observed in two chiropractic patients (Q33692765) (← links)
- Management of a mixed overdose of calcium channel blockers, β-blockers and statins (Q33743700) (← links)
- Genealogical analysis as a new approach for the investigation of drug intolerance heritability (Q33765249) (← links)
- Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial (Q33770940) (← links)
- Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia? (Q33776187) (← links)
- Myopathy in Patients Taking Atorvastatin: A Pilot Study (Q33815469) (← links)
- Applied pharmacogenomics in cardiovascular medicine (Q33846255) (← links)
- Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database (Q33867311) (← links)
- A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design (Q33937142) (← links)
- Correlates of fatigue in patients with heart failure. (Q33938091) (← links)
- Statin therapy and the expression of genes that regulate calcium homeostasis and membrane repair in skeletal muscle (Q33947257) (← links)
- Safety of statins: an update (Q33949312) (← links)
- Statins and their interactions with other lipid-modifying medications: safety issues in the elderly (Q33949348) (← links)
- Imaging of zebrafish in vivo with second-harmonic generation reveals shortened sarcomeres associated with myopathy induced by statin (Q34037784) (← links)
- Pharmacogenomics: a systems approach (Q34137575) (← links)